Francisco Partners to Acquire Weave for Approximately $650 Million - Report - DentalSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Francisco Partners to Acquire Weave for Approximately $650 Million

  • By

  • News Staff

  • August 25, 2026

Share

Clinical Report: Francisco Partners to Acquire Weave for Approximately $650 Million

Overview

Weave Communications, Inc. has agreed to be acquired by Francisco Partners for approximately $650 million, with stockholders receiving $7.40 per share in cash.

Background

The acquisition of Weave by Francisco Partners indicates a significant market presence, as Weave's platform serves over 40,000 locations. The transaction reflects ongoing private equity investment in healthcare technology companies.

Data Highlights

No numerical or trial data available in the source material.

Key Findings

  • Weave will be acquired for approximately $650 million, with a premium of 34% over its stock price prior to the announcement.
  • Stockholders will receive $7.40 per share in cash upon completion of the acquisition.
  • Weave has built a platform that integrates AI into patient communications and practice management.
  • The acquisition is expected to close in the fourth quarter of 2026, pending stockholder and regulatory approvals.
  • Weave's technology includes functions for scheduling, insurance verification, and payments.

Clinical Implications

The acquisition may lead to enhanced investment in AI technologies that improve patient engagement and operational efficiency in healthcare practices. As Weave continues to operate under its brand, its focus on independent practices may influence future developments in patient communication strategies.

Conclusion

The acquisition of Weave by Francisco Partners is a transaction that will result in Weave becoming a privately held company.

Related Resources & Content

  1. ADA News, ADA Member Advantage endorses Weave as patient engagement platform, 2026 -- ADA Member Advantage endorses Weave as patient engagement platform
  2. the medicine maker, Business-in-Brief, 2019 -- Business-in-Brief
  3. Eyecare Business, Marcolin Acquires Viva International Group, 2013 -- Marcolin Acquires Viva International Group
  4. the medicine maker — A Turbulent Transaction?
  5. A systematic review and meta-analysis of appointment reminders for enhancing hospital attendance - Al-Turbag - Journal of Hospital Management and Health Policy
  6. Behaviorally Informed Text Messaging to Promote Colon Cancer Screening: A Quality Improvement Randomized Clinical Trial | Gastroenterology and Hepatology | JAMA Network Open | JAMA Network
  7. oup.silverchair-cdn.com
  8. SAFER Guides - ONC - Office of the National Coordinator for Health Information Technology
  9. 2026 CMS QRDA III Eligible Clinicians Implementation Guide v1.1
  10. Patient Demographics/Information | Immunization Information Systems (IIS) | CDC
  11. https://www.ada.org/-/media/project/ada-organization/ada/ada-org/files/resources/practice/dental-standards/aip-review/2026/1084_aip_review_feb_2026.pdf?hash=2E67EC643826E1F0C130DCD56EF4E458&rev=f23d136cb6024792b6fcb3c66a54e4a4

Original Source(s)

Related Content